InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,066.40
(
0.28%
)
Dow Jones
39,357.01
(
-0.36%
)
Brent Oil
81.34
(
-0.33%
)
Bitcoin
59,096.91
(
-0.44%
)
Post# of 252864
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 835
Posts 120262
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: pollyvonwog post# 117403

Thursday, 03/31/2011 5:46:38 PM

Thursday, March 31, 2011 5:46:38 PM

Post# of 252864

TEVA/MNTA—You still have one more day before you're off the hook DD! :)

I’m not especially worried insofar as I highly doubt that Teva has even submitted its response to the FDA’s deficiency letter.

The more pertinent question, IMO, is whether Teva intends to submit a response at all.

Now that Teva can no longer get any mileage out of hyping its Lovenox program to the investment community (thanks to NVS/MNTA’s lawsuit), Teva might reason that there is more downside than upside in responding to the FDA and thereby exposing Teva to additional avenues of legal discovery in the patent-infringement case.

As PGS noted a while ago… enox-o-what?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up